Biochemical, immunological, and cell genetic studies in glycogenosis type II
- PMID: 350041
- PMCID: PMC1685555
Biochemical, immunological, and cell genetic studies in glycogenosis type II
Abstract
Fibroblasts from patients with the adult, juvenile, and infantile form of glycogenosis type II (Pompe disease) were cultured under standardized conditions, and the activity of acid alpha-glucosidase (E.C.3.2.1.20) towards glycogen, maltose, and 4-methylumbelliferyl-alpha-D-glucopyranoside was measured. Glycogen levels in muscle biopsies and in cultured fibroblasts from patients were determined. Residual enzyme activities varying from 7%-22% were detected in fibroblasts from patients with the adult form but not from patients with the infantile form of glycogenosis II. An inverse correlation was found between the severity of the clinical manifestation and the degree of residual enzyme activity in the fibroblasts. The kinetic and electrophoretic properties of acid alpha-glucosidase in fibroblasts from the adult patients and from control individuals were similar. Immunological studies suggested that the decrease of acid alpha-glucosidase activity is caused by a mutation that affects the production or degradation of the enzyme rather than its catalytic activity. Complementation studies were carried out by fusing fibroblasts from patients with the adult, juvenile, and infantile form of glycogenosis II, but neither conventional assays on multikaryons nor enzyme assays on single binuclear heterokaryons gave any evidence for genetic heterogeneity among these forms.
Similar articles
-
[Characterization of alpha-glucosidase in skin fibroblasts in the diagnosis of glycogenosis type 2 (Pompe disease)].Kinderarztl Prax. 1984 Aug;52(8):377-82. Kinderarztl Prax. 1984. PMID: 6384623 German. No abstract available.
-
Adult forms of glycogenosis type II. A defect in an early stage of acid alpha-glucosidase realization.FEBS Lett. 1982 Sep 20;146(2):361-4. doi: 10.1016/0014-5793(82)80953-8. FEBS Lett. 1982. PMID: 6754447
-
Immunochemical studies of human acid alpha-1,4-glucosidase in type II glycogenosis.Enzyme. 1981;26(4):182-90. doi: 10.1159/000459173. Enzyme. 1981. PMID: 7018896
-
Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).Curr Mol Med. 2002 Mar;2(2):145-66. doi: 10.2174/1566524024605789. Curr Mol Med. 2002. PMID: 11949932 Review.
-
alpha-Glucosidase deficiency (Pompe's disease).Enzyme. 1987;38(1-4):280-5. doi: 10.1159/000469217. Enzyme. 1987. PMID: 3126044 Review.
Cited by
-
Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.J Biol Chem. 2015 Jan 30;290(5):3121-36. doi: 10.1074/jbc.M114.628628. Epub 2014 Dec 8. J Biol Chem. 2015. PMID: 25488666 Free PMC article.
-
Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical Trials.Viruses. 2024 Mar 5;16(3):400. doi: 10.3390/v16030400. Viruses. 2024. PMID: 38543765 Free PMC article.
-
Pompe's disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity.J Inherit Metab Dis. 1987;10(1):11-7. doi: 10.1007/BF01799482. J Inherit Metab Dis. 1987. PMID: 3106710
-
Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts.J Clin Invest. 1987 Jun;79(6):1689-99. doi: 10.1172/JCI113008. J Clin Invest. 1987. PMID: 3108320 Free PMC article.
-
The Respiratory Phenotype of Pompe Disease Mouse Models.Int J Mol Sci. 2020 Mar 24;21(6):2256. doi: 10.3390/ijms21062256. Int J Mol Sci. 2020. PMID: 32214050 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources